S R Durham| - JoVE Visualize

Showing results (171-180 of 209) with videos related to

Pageof 21

Sort By:

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 3, 2008

BSACI guidelines for the management of rhinosinusitis and nasal polyposisG K Scadding, S R Durham, R Mirakian, et al.

American Journal of Respiratory and Critical Care Medicine|July 9, 1998

Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthmaK Rajakulasingam, S Till, S Ying, et al.

Nature Medicine|January 1, 1995

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosisN J Caplen, E W Alton, P G Middleton, et al.

Allergy|February 13, 2010

CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responsesG Banfield, H Watanabe, G Scadding, et al.

Allergy|November 15, 2011

Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapyM H Shamji, C Ljørring, J N Francis, et al.

Allergy|March 12, 2015

Inhibition of allergen-dependent IgE activity by antibodies of the same specificity but different classT S Dodev, H Bowen, M H Shamji, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006

Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.

Allergy|March 17, 2015

Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challengeG W Scadding, A O Eifan, M Lao-Araya, et al.

Allergy|November 4, 2005

Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challengeE M Erin, B R Leaker, A S Zacharasiewicz, et al.

Allergy|November 19, 2017

A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapyR Mösges, E M Kasche, E Raskopf, et al.

Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:

Pageof 21

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 3, 2008

BSACI guidelines for the management of rhinosinusitis and nasal polyposisG K Scadding, S R Durham, R Mirakian, et al.

American Journal of Respiratory and Critical Care Medicine|July 9, 1998

Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthmaK Rajakulasingam, S Till, S Ying, et al.

Nature Medicine|January 1, 1995

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosisN J Caplen, E W Alton, P G Middleton, et al.

Allergy|February 13, 2010

CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responsesG Banfield, H Watanabe, G Scadding, et al.

Allergy|November 15, 2011

Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapyM H Shamji, C Ljørring, J N Francis, et al.

Allergy|March 12, 2015

Inhibition of allergen-dependent IgE activity by antibodies of the same specificity but different classT S Dodev, H Bowen, M H Shamji, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006

Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.

Allergy|March 17, 2015

Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challengeG W Scadding, A O Eifan, M Lao-Araya, et al.

Allergy|November 4, 2005

Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challengeE M Erin, B R Leaker, A S Zacharasiewicz, et al.

Allergy|November 19, 2017

A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapyR Mösges, E M Kasche, E Raskopf, et al.

Pageof 21